Skip to content

Quantitative Flow Ratio Virtual Stenting and Angiography Guided Percutaneous Coronary Intervention: A Prospective, Multi-Center, Randomized Control Study

Quantitative Flow Ratio Virtual Stenting and Angiography Guided Percutaneous Coronary Intervention: A Prospective, Multi-Center, Randomized Control Study - QUITE RIGHT Study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045452
Enrollment
Unknown
Registered
2021-04-15
Start date
2022-10-18
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronnary Artery Disease

Interventions

experimental group:virtual stent
control group:Conventional treatment

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Chronic coronary syndrome; 3. 72 hours after NTSE-ACS or STEMI; 4. Able to understand the purpose of this experiment and sign an informed consent form; 5. The surgeon believes that the patients disease requires interventional therapy with drug-eluting stents; 6. Coronary angiography selection criteria: There is at least one lesion with a visual stenosis of 50%-90% (inclusive) on a coronary vessel with a visual reference lumen diameter >= 2.5 mm.

Exclusion criteria

Exclusion criteria: 1. Cardiogenic shock or severe heart failure (NYHA >= grade III); 2. End-stage renal disease required dialysis; 3. Allergic to iodine-containing contrast media; 4. Women during pregnancy; 5. The expected survival time is less than 1 year. 6. Coronary angiography exclusion criteria: (1) The target lesion involves myocardial bridge; (2) The target lesion is located in the graft vessel; (3) Severe calcification of the target lesion; (4) Inability to detect blood vessel boundaries or low-quality angiography with poor contrast agent filling; (5) For lesions with excessively overlapping stenoses or severely distorted target vessels, QFR is not expected to be performed.

Design outcomes

Primary

MeasureTime frame
the proportion of target vessel QFR >= 0.90;

Countries

China

Contacts

Public ContactChe Lianglong

Fujian Medical University Union Hospital

lianglongchen@126.com+86 139 5030 3022

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026